LSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeLSE
Market Capitalization210,824 mln
Float1,541 mln
Earnings Date07/27/2026
EPS
497
Exceptional
P / E
27.09
Elevated
Piotroski F-Score
9
/ 9
Exceptional
Beneish M-Score
-2.59
Likely reliable
1-Year Forecast
16,523
Attractive
Relative Strength
25
/ 100
Underperforming
Business Description
AstraZeneca is a global medicine company headquartered in Cambridge, UK, focused on researching, making, and selling prescription treatments across a wide range of serious health conditions, including cancer, heart and kidney disease, respiratory illness, and rare disorders. The company markets a broad portfolio of well-known medicines and vaccines, serving both general practitioners and specialist doctors through distribution networks and sales offices across every major region of the world. Originally formed through the 1999 merger of Zeneca and Astra, AstraZeneca continues to expand its capabilities through partnerships with other organisations aimed at advancing drug discovery and developing new therapies.
